Messoud Ashina

Has grant

Professor

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Messoud Ashina is a Professor at Rigshospitalet Glostrup in Denmark. His research areas focus on migraine pathology and treatment effectiveness, with recent articles exploring topics such as the burden of migraine in the population, cortical morphometry in headache disorders, and the mechanisms underlying migraine triggers. He is actively involved in studies examining both the safety and efficacy of various migraine therapies, contributing to advancements in the field.

Recent Grants

Grant: Close

Molecular signaling pathways and functional features of the migraine brain

Open Date: 2020-01-01

Close Date: 2025-12-01

Grant: Close

Investigation of extracranial vascular hyper-reactivity in rosacea and migraine patients using experimental models

Open Date: 2018-01-01

Close Date: 2020-12-31

Grant: Close

Investigation of vascular inflammation in migraine without aura using molecular nano-imaging and black blood imaging MRI.

Open Date: 2015-11-02

Close Date: 2018-07-01

Grant: Close

Models and biomarkers of migraine

Open Date: 2015-01-01

Close Date: 2023-01-01

Grant: Close

Pathophysiological Mechanisms of Migraine with Aura in Humans

Open Date: 2014-01-01

Close Date: 2014-12-31

Articles (24)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Collaborators (8)

Jan Versijpt

Vrije Universiteit Brussel

BELGIUM

View details

Patricia Pozo-Rosich

SPAIN

View details

Debbie Hay

University of Otago

NEW ZEALAND

View details

Sait Ashina

Assistant Professor

Harvard Medical School

UNITED STATES

View details

Anders Hougaard

DENMARK

View details

Faisal Mohammad Amin

Associate Professor

University of Copenhagen

DENMARK

View details

Lanfranco Pellesi

DENMARK

View details

Christoph J. Schankin

SWITZERLAND

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Messoud Ashina

Research Interests

Contact this professor

About

Recent Grants

Articles (24)

Lost earnings among triptan non-responders in the general population of Denmark: a measure of disproportionate migraine-attributed burden and of unrecognised and unmet treatment need

Long-term real-world effectiveness and safety of fremanezumab in 1140 patients with migraine and at least 6 months of treatment: third interim analysis of the pan-European PEARL study

Differences in cortical morphometry between persistent post-traumatic headache, migraine and healthy controls

Long-term safety, efficacy and functional outcomes of atogepant for the preventive treatment of migraine

Opening of ATP-sensitive potassium channels activates meningeal nociceptors: Implications for the origin of migraine headache

Overlap between perceived triggers, premonitory symptoms and symptom persistence across migraine phases: A REFORM study

Plasma adrenomedullin levels in migraine: A registry for migraine (REFORM) study

Substance P and the trigeminovascular system: From preclinical mechanisms to human headache induction

Effect of sumatriptan on ATP-sensitive potassium channel opening in migraine: A randomised controlled trial

The mysterious link between migraine aura and migraine headache

Pituitary adenylate cyclase-activating polypeptide signalling as a therapeutic target in migraine

The headache research priorities: Research goals from the American Headache Society and an international multistakeholder expert group

Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial

Long‐term efficacy and safety of erenumab in patients with chronic migraine and acute medication overuse: A subgroup analysis

Migraine aura‐like episodes following sclerotherapy for varicose veins of the lower extremities—A systematic review

Once‐daily oral atogepant for the long‐term preventive treatment of migraine: Findings from a multicenter, randomized, open‐label, phase 3 trial

Numbers needed to treat or harm and likelihood of being helped versus harmed for fremanezumab in patients who had prior inadequate response to two to four classes of migraine preventive medications: A post hoc analysis

Cluster headache – The worst possible pain on YouTube

Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis

Greater Occipital Nerve Block with Local Anesthetics and Corticosteroids in Treatment-Resistant Chronic Migraine

Board Walk - August 2021.

Reduction in acute migraine-specific and non-specific medication use in patients treated with erenumab: post-hoc analyses of episodic and chronic migraine clinical trials.

Structured Q1 headache services as the solution to the ill-health burden of headache: 1. Rationale and description.

Future prophylactic treatments in migraine: Beyond anti-CGRP monoclonal antibodies and gepants.

Collaborators (8)

Jan Versijpt

Patricia Pozo-Rosich

Debbie Hay

Sait Ashina

Anders Hougaard

Faisal Mohammad Amin

Lanfranco Pellesi

Christoph J. Schankin

Make your next move.